Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. H. Garrett
3,3'-Diindolylmethane Enhances the Efficacy of Butyrate in Colon Cancer Prevention Through Down-Regulation of Survivin
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Related publications
3,3'-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer
Cancer Research
Cancer Research
Oncology
3,3′-Diindolylmethane Enhances Glucose Uptake Through Activation of Insulin Signaling in 3t3-L1 Adipocytes
Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Up-Regulation of 5-Lipoxygenase by Inhibition of Cathepsin G Enhances TRAIL-induced Apoptosis Through Down-Regulation of Survivin
Oncotarget
Oncology
Down-Regulation of uPA and uPAR by 3,3′-Diindolylmethane Contributes to the Inhibition of Cell Growth and Migration of Breast Cancer Cells
Journal of Cellular Biochemistry
Biochemistry
Cell Biology
Molecular Biology
Survivin Enhances Fas Ligand Expression via Up-Regulation of Specificity Protein 1-Mediated Gene Transcription in Colon Cancer Cells
Journal of Immunology
Allergy
Immunology
Retraction: “Down-Regulation of uPA and uPAR by 3,3′-Diindolylmethane Contributes to the Inhibition of Cell Growth and Migration of Breast Cancer Cells” by Ahmad Et Al.
Journal of Cellular Biochemistry
Biochemistry
Cell Biology
Molecular Biology
3,3′-Diindolylmethane: A Promising Sensitizer Ofγ-Irradiation
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
EZH2 Inhibition Enhances the Efficacy of an EGFR Inhibitor in Suppressing Colon Cancer Cells
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
3,3′-Diindolylmethane Ameliorates Renal Fibrosis Through the Inhibition of Renal Fibroblast Activation in Vivo and in Vitro
Renal Failure
Medicine
Nephrology
Critical Care
Intensive Care Medicine
